Program & Sessions

View the program descriptions and enter the sessions.

Faculty

Read more about the Faculty presenting on the sessions.

Exhibit Hall

View Exhibit booths and chat with a exhibitor



image
Dr. John Ultmann

This annual conference is dedicated to honor Dr. Ultmann who became an internationally known pioneer in the efforts to distinguish between the different types of lymphoma. He also developed treatments for the stages of Hodgkin's disease and non-Hodgkin's lymphoma and taught compassionate care to medical students.

We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.

This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting is being held virtually on Friday and Saturday and will include a combination of expert presentations, a hematopathology multidisciplinary tumor board discussion, mini symposiums on FLL, CLL, R/R DLBCL, T-cell Lymphoma, and a nursing session.

Virtual symposium components will include:
•    LIVE stream session broadcast in real time
•    Opportunities to submit questions to presenters during the live broadcast
•    Ability to interact with other virtual participants via symposium attendee chat tool
•    Access to the virtual exhibit hall for connectivity and information
•    CME and MOC credits for physicians and CNE credits for nurses
•    Access to download presenter slide decks approved for release

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  1. Distinguish between the different treatment approaches for newly diagnosed T-cell lymphoma and mantle cell lymphoma
  2. Discuss the role of allogeneic stem cell transplant in Hodgkin lymphoma treatment
  3. Identify patient characteristics best suited for CAR T-cell treatment
  4. Differentiate between the different lymphoma staging and re-staging classifications to develop an appropriate patient treatment plan
  5. Evaluate the different treatment options for follicular lymphoma and the risk of transformation to other cancers
  6. State key environmental and genetics risks for lymphoma and the roles they play in lymphoid malignancies
  7. Outline key molecular and cytogenetic information in order to determine best treatment options for chronic lymphocytic leukemia
  8. Determine short and long-term toxicities of cardiotoxic agents used in lymphoma treatment
  9. Describe how epigenetic targets in lymphoid cancers can be used to improve patient outcomes
  10. List non-chemotherapy options for follicular lymphoma

Accreditation

Physician Credit The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit The University of Chicago Medicine is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

This live activity is designated for a maximum of 11.75 continuing nursing education units.

American Board of Internal Medicine MOC Part II Credit Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Healthcare Professions Credit Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Target Audience

The symposium has been designed for medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals committed to the diagnosis and treatment of lymphoma.

image